TY  - JOUR

T1  - Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting

JO  - Frontiers in Oncology

UR  - https://doi.org/10.3389/fonc.2025.1556881

PY  - 2025/04/02

AU  - Saha S

AU  - Gerdtham U-G

AU  - Sjödahl G

AU  - Häggström C

AU  - Catto JWF

AU  - Kelly JD

AU  - Ullén A

AU  - Holmberg L

AU  - Liedberg F

ED  - 

DO  - DOI: 10.3389/fonc.2025.1556881

PB  - Frontiers Media SA

VL  - 15

Y2  - 2025/04/27

ER  -